Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TerveystaloTTALF -30.89%69 EBITDA Margin % is 16.02% as of Jun. 2026, which is 1% above its 10-year median of 15.86. GuruFocus rates TTALF with a GF Score™ of 69/100 and a GF Value™ of $10.12. The stock has 5 warning signs investors should review. Among 671 Healthcare Providers & Services companies, Terveystalo ranks better than 68.11% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Terveystalo's EBITDA for the
three
months ended in Jun. 2026 was $54 Mil. Terveystalo's Revenue for the
three
months ended in Jun. 2026 was $338 Mil. Therefore, Terveystalo's EBITDA margin for the quarter that ended in Jun. 2026 was 16.02%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Terveystalo EBITDA Margin % Related Terms
Terveystalo EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Terveystalo's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TTALF vs HCA, THC, EHC: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Terveystalo's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Terveystalo EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Terveystalo's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Terveystalo's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terveystalo (TTALF) has a EBITDA Margin % of 16.02% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Terveystalo and its competitors. This is near median its historical median of 15.86. Over the past decade, Terveystalo's EBITDA Margin % has ranged from 7.05 to 18.20. According to the industry distribution chart, Terveystalo ranks #214 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 31.9%.
Is Terveystalo's EBITDA Margin % too high?
Terveystalo's current EBITDA Margin % of 16.02% is near median its 10-year median of 15.86. Over the past 10 years, this metric has ranged from a low of 7.05 to a high of 18.20. The Healthcare Providers & Services industry median EBITDA Margin % is 10.09. Terveystalo's value of 16.02% is 58.8% above this industry median. Based on the distribution chart, Terveystalo ranks #214 out of 671 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Terveystalo has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Terveystalo's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Terveystalo ranks #214 out of 671 companies for EBITDA Margin %. This puts Terveystalo in the upper half of its industry. The industry median EBITDA Margin % is 10.09. Terveystalo's value of 16.02% is 58.8% above this benchmark. Historically, Terveystalo's own EBITDA Margin % has ranged from 7.05 to 18.20 over the past decade. While the company's 10-year median is 15.86 vs. the industry median of 10.09, Terveystalo has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.09, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Terveystalo's current EBITDA Margin % of 16.02% is 58.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Terveystalo and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Terveystalo's current EBITDA Margin % is 16.02%, which is near median its own 10-year median of 15.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terveystalo stock overvalued right now?
Terveystalo (TTALF) has a current EBITDA Margin % of 16.02%. The stock's GF Value™ is $10.12, compared to a current price of $8.95 — trading 11.6% below its estimated fair value. The current EBITDA Margin % is 16.02%, which is near median its 10-year median of 15.86 and 58.8% above the Healthcare Providers & Services industry median of 10.09. Terveystalo's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Terveystalo (TTALF), the current EBITDA Margin % is 16.02% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Terveystalo (TTALF) Overvalued in 2026?
Based on GuruFocus' analysis, Terveystalo stock appears to be undervalued.
The current stock price of $8.95 is trading 11.6% below its estimated GF Value™ of $10.12.
Key valuation signals for TTALF:
EBITDA Margin %: 16.02% (near median its 10-year median of 15.86)
GF Value™: $10.12 vs. price of $8.95 (11.6% below fair value)
Industry Position: 58.8% above the Healthcare Providers & Services median (#214 of 671)
No single metric tells the full story. See the TTALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Terveystalo PLC o is a healthcare service provider in Finland. The company offers primary and specialized healthcare services to corporate, private, and public sector customers. The healthcare service offering of the company includes general practice and specialist medical care, diagnostic services, outpatient surgery, dental services and other adjacent services; it covers the entire integrated treatment chain of healthcare. The Group comprises of three reporting segments: Healthcare Services, Portfolio Businesses, and Sweden, out of which it derives maximum revenue from Healthcare Services segment.
69GF Score
Get the complete analysis for TTALF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TTALF has been successfully added to your 
